Molecular and cellular analysis of human histamine receptor subtypes.

[1]  L. Palmqvist,et al.  Remission maintenance in acute myeloid leukemia: impact of functional histamine H2 receptors expressed by leukemic cells , 2012, Haematologica.

[2]  R. Leurs,et al.  Analysis of Multiple Histamine H4 Receptor Compound Classes Uncovers Gαi Protein- and β-Arrestin2-Biased Ligands , 2012, Molecular Pharmacology.

[3]  R. Seifert,et al.  Evidence for ligand-specific conformations of the histamine H(2)-receptor in human eosinophils and neutrophils. , 2012, Biochemical pharmacology.

[4]  J. Azorin,et al.  Clozapine for the treatment of schizophrenia , 2012, Expert opinion on pharmacotherapy.

[5]  R. Seifert,et al.  Incomplete activation of human eosinophils via the histamine H4-receptor: evidence for ligand-specific receptor conformations. , 2012, Biochemical pharmacology.

[6]  R. Stevens,et al.  Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions , 2012, Science.

[7]  M. Grimm,et al.  Prognostic value of histamine H1 receptor expression in oral squamous cell carcinoma , 2012, Clinical Oral Investigations.

[8]  W. Lamers,et al.  Specificity evaluation of antibodies against human β3-adrenoceptors , 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

[9]  R. Seifert,et al.  Problems associated with the use of commercial and non-commercial antibodies against the histamine H4 receptor , 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

[10]  C. Rhee,et al.  Histamine regulates mucin expression through H1 receptor in airway epithelial cells , 2012, Acta oto-laryngologica.

[11]  T. Kuroishi,et al.  Histamine reduces susceptibility to natural killer cells via down‐regulation of NKG2D ligands on human monocytic leukaemia THP‐1 cells , 2012, Immunology.

[12]  R. Leurs,et al.  Well characterized antihistamine 4 receptor antibodies contribute to current knowledge of the expression and biology of the human and murine histamine 4 receptor , 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

[13]  T. Kenakin Biased signalling and allosteric machines: new vistas and challenges for drug discovery , 2012, British journal of pharmacology.

[14]  R. Kiss,et al.  Histamine H4 receptor ligands and their potential therapeutic applications: an update , 2012, Expert opinion on therapeutic patents.

[15]  A. Falus,et al.  Characterization and Function of Histamine Receptors in Human Bone Marrow Stromal Cells , 2012, Stem cells.

[16]  N. Trier,et al.  Production and characterization of peptide antibodies. , 2012, Methods.

[17]  Wei Guo,et al.  Potential role of store-operated Ca2+ entry in Th2 response induced by histamine in human monocyte-derived dendritic cells. , 2012, International immunopharmacology.

[18]  A. Strasser,et al.  Interactions of recombinant human histamine H1, H2, H3, and H4 receptors with 34 antidepressants and antipsychotics , 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

[19]  R. Seifert,et al.  The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H₂ receptor agonists. , 2012, Journal of medicinal chemistry.

[20]  Hans-Joachim Wittmann,et al.  Influence of the N-terminus and the E2-loop onto the binding kinetics of the antagonist mepyramine and the partial agonist phenoprodifen to H(1)R. , 2011, Biochemical pharmacology.

[21]  R. Seifert,et al.  Commercially available antibodies against human and murine histamine H4-receptor lack specificity , 2011, Naunyn-Schmiedeberg's Archives of Pharmacology.

[22]  Hans-Joachim Wittmann,et al.  Mepyramine-JNJ7777120-hybrid compounds show high affinity to hH(1)R, but low affinity to hH(4)R. , 2011, Bioorganic & medicinal chemistry letters.

[23]  F. Ducancel,et al.  Electroporation-aided DNA immunization generates polyclonal antibodies against the native conformation of human endothelin B receptor. , 2011, DNA and cell biology.

[24]  A. Strasser,et al.  Role of the second and third extracellular loops of the histamine H4 receptor in receptor activation , 2011, Naunyn-Schmiedeberg's Archives of Pharmacology.

[25]  Hans-Joachim Wittmann,et al.  Nα-Methylated phenylhistamines exhibit affinity to the hH4R—a pharmacological and molecular modelling study , 2011, Naunyn-Schmiedeberg's Archives of Pharmacology.

[26]  N. Takeda,et al.  Involvement of Protein Kinase Cδ/Extracellular Signal-regulated Kinase/Poly(ADP-ribose) Polymerase-1 (PARP-1) Signaling Pathway in Histamine-induced Up-regulation of Histamine H1 Receptor Gene Expression in HeLa Cells* , 2011, The Journal of Biological Chemistry.

[27]  Ruben Abagyan,et al.  Structure of the human histamine H1 receptor complex with doxepin , 2011, Nature.

[28]  C. Shayo,et al.  Roles of Phosphorylation-dependent and -independent Mechanisms in the Regulation of Histamine H2 Receptor by G Protein-coupled Receptor Kinase 2* , 2011, The Journal of Biological Chemistry.

[29]  R. Seifert,et al.  Impact of fusion to Gαi2 and co‐expression with RGS proteins on pharmacological properties of human cannabinoid receptors CB1R and CB2R , 2011, The Journal of pharmacy and pharmacology.

[30]  R. Gutzmer,et al.  Pathogenetic and therapeutic implications of the histamine H4 receptor in inflammatory skin diseases and pruritus. , 2011, Frontiers in bioscience.

[31]  J. Schwartz,et al.  The histamine H3 receptor: from discovery to clinical trials with pitolisant , 2011, British journal of pharmacology.

[32]  Lei Shi,et al.  Attenuated expression of HRH4 in colorectal carcinomas: a potential influence on tumor growth and progression , 2011, BMC Cancer.

[33]  M. Grimm,et al.  Allergic Predisposition, Histamine and Histamine Receptor Expression (H1R, H2R) Are Associated with Complicated Courses of Sigmoid Diverticulitis , 2011, Journal of Gastrointestinal Surgery.

[34]  R. Fass,et al.  Pharmacological management of GERD: where does it stand now? , 2011, Trends in pharmacological sciences.

[35]  N. Shankley,et al.  The scientific legacy of Sir James W. Black. , 2011, Trends in pharmacological sciences.

[36]  I. D. de Esch,et al.  En route to new blockbuster anti-histamines: surveying the offspring of the expanding histamine receptor family. , 2011, Trends in pharmacological sciences.

[37]  S. Charlton,et al.  Agonist-Biased Signaling at the Histamine H4 Receptor: JNJ7777120 Recruits β-Arrestin without Activating G Proteins , 2011, Molecular Pharmacology.

[38]  A. Strasser,et al.  Paradoxical Stimulatory Effects of the “Standard” Histamine H4-Receptor Antagonist JNJ7777120: the H4 Receptor Joins the Club of 7 Transmembrane Domain Receptors Exhibiting Functional Selectivity , 2011, Molecular Pharmacology.

[39]  A. Newman-Tancredi,et al.  Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties , 2011, Psychopharmacology.

[40]  F. Carvalho,et al.  Haematological toxicity of clozapine and some other drugs used in psychiatry , 2011, Human psychopharmacology.

[41]  Corina I. García,et al.  Multidrug Resistance Protein 4 (MRP4/ABCC4) Regulates cAMP Cellular Levels and Controls Human Leukemia Cell Proliferation and Differentiation* , 2011, The Journal of Biological Chemistry.

[42]  Patrick Igel,et al.  Histamine H4 receptor agonists. , 2010, Bioorganic & medicinal chemistry letters.

[43]  R. Seifert,et al.  Sf9 cells: a versatile model system to investigate the pharmacological properties of G protein-coupled receptors. , 2010, Pharmacology & therapeutics.

[44]  S. Rasmussen,et al.  Structure of a nanobody-stabilized active state of the β2 adrenoceptor , 2010, Nature.

[45]  A. Strasser,et al.  Comparison of the pharmacological properties of human and rat histamine H(3)-receptors. , 2010, Biochemical pharmacology.

[46]  Roland Seifert,et al.  Structural Requirements for Inverse Agonism and Neutral Antagonism of Indole-, Benzimidazole-, and Thienopyrrole-Derived Histamine H4 Receptor Ligands , 2010, Journal of Pharmacology and Experimental Therapeutics.

[47]  A. Magnan,et al.  Histamine induces Th2 activation through the histamine receptor 1 in house dust mite rhinitic but not asthmatic patients , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[48]  Wen Jiang,et al.  Molecular Determinants of Ligand Binding to H4R Species Variants , 2010, Molecular Pharmacology.

[49]  A. Strasser,et al.  Impact of the DRY Motif and the Missing “Ionic Lock” on Constitutive Activity and G-Protein Coupling of the Human Histamine H4 Receptor , 2010, Journal of Pharmacology and Experimental Therapeutics.

[50]  Keshava Rajagopal,et al.  Teaching old receptors new tricks: biasing seven-transmembrane receptors , 2010, Nature Reviews Drug Discovery.

[51]  D. Stechschulte,et al.  Lipopolysaccharide induces H1 receptor expression and enhances histamine responsiveness in human coronary artery endothelial cells , 2010, Immunology.

[52]  J. Bousquet,et al.  Risk of first‐generation H1‐antihistamines: a GA2LEN position paper , 2010, Allergy.

[53]  R. Seifert,et al.  Modulation of histamine H3 receptor function by monovalent ions , 2010, Neuroscience Letters.

[54]  R. Seifert,et al.  No Evidence for Functional Selectivity of Proxyfan at the Human Histamine H3 Receptor Coupled to Defined Gi/Go Protein Heterotrimers , 2010, Journal of Pharmacology and Experimental Therapeutics.

[55]  C. Akdis,et al.  Histamine, histamine receptors and their role in immune pathology , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[56]  A. Strasser,et al.  Interactions of Histamine H1-Receptor Agonists and Antagonists with the Human Histamine H4-Receptor , 2009, Molecular Pharmacology.

[57]  A. Strasser,et al.  Synthesis and Structure−Activity Relationships of Cyanoguanidine-Type and Structurally Related Histamine H4 Receptor Agonists§ , 2009 .

[58]  R. Seifert,et al.  Histamine H(4) receptor-RGS fusion proteins expressed in Sf9 insect cells: a sensitive and reliable approach for the functional characterization of histamine H(4) receptor ligands. , 2009, Biochemical pharmacology.

[59]  M. Gillard,et al.  H4 Histamine Receptors Mediate Cell Cycle Arrest in Growth Factor-Induced Murine and Human Hematopoietic Progenitor Cells , 2009, PloS one.

[60]  Hans-Joachim Wittmann,et al.  Contribution of Binding Enthalpy and Entropy to Affinity of Antagonist and Agonist Binding at Human and Guinea Pig Histamine H1-Receptor , 2009, Molecular Pharmacology.

[61]  B. Jensen,et al.  Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

[62]  P. Spano,et al.  Should we be cautious on the use of commercially available antibodies to dopamine receptors? , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

[63]  Wolfgang Kummer,et al.  Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

[64]  R. Seifert,et al.  N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent. , 2009, Journal of medicinal chemistry.

[65]  Hans-Joachim Wittmann,et al.  Molecular Basis for the Selective Interaction of Synthetic Agonists with the Human Histamine H1-Receptor Compared with the Guinea Pig H1-Receptor , 2009, Molecular Pharmacology.

[66]  H. Stark,et al.  The histamine H4 receptor is functionally expressed on T(H)2 cells. , 2009, The Journal of allergy and clinical immunology.

[67]  Roland Seifert,et al.  High constitutive activity and a G-protein-independent high-affinity state of the human histamine H(4)-receptor. , 2009, Biochemistry.

[68]  R. Seifert,et al.  NG‐Acylated Aminothiazolylpropylguanidines as Potent and Selective Histamine H2 Receptor Agonists , 2009, ChemMedChem.

[69]  R. Seifert,et al.  Tritium‐Labeled N1‐[3‐(1H‐imidazol‐4‐yl)propyl]‐N2‐propionylguanidine ([3H]UR‐PI294), a High‐Affinity Histamine H3 and H4 Receptor Radioligand , 2009, ChemMedChem.

[70]  N. F. Dabhoiwala,et al.  Lack of specificity of commercially available antisera against muscarinergic and adrenergic receptors , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

[71]  T. Wieland,et al.  How reliable are G-protein-coupled receptor antibodies? , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

[72]  J. Velden,et al.  Lack of specificity of antibodies directed against human beta-adrenergic receptors , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

[73]  Holger Stark,et al.  Histamine H3 receptor antagonists go to clinics. , 2008, Biological & pharmaceutical bulletin.

[74]  Jill M. Wetter,et al.  cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia. , 2008, Journal of medicinal chemistry.

[75]  R. Smits,et al.  Discovery of quinazolines as histamine H4 receptor inverse agonists using a scaffold hopping approach. , 2008, Journal of medicinal chemistry.

[76]  R. Seifert,et al.  Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists. , 2008, Journal of medicinal chemistry.

[77]  I. D. de Esch,et al.  Phenylalanine 169 in the Second Extracellular Loop of the Human Histamine H4 Receptor Is Responsible for the Difference in Agonist Binding between Human and Mouse H4 Receptors , 2008, Journal of Pharmacology and Experimental Therapeutics.

[78]  Hans-Joachim Wittmann,et al.  Ligand-Specific Contribution of the N Terminus and E2-Loop to Pharmacological Properties of the Histamine H1-Receptor , 2008, Journal of Pharmacology and Experimental Therapeutics.

[79]  Donard S Dwyer,et al.  Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection , 2008, Pharmacological Reviews.

[80]  H. Haas,et al.  Histamine in the nervous system. , 2008, Physiological reviews.

[81]  Robert Kiss,et al.  Activation Mechanism of the Human Histamine H4 Receptor - An Explicit Membrane Molecular Dynamics Simulation Study , 2008, J. Chem. Inf. Model..

[82]  Hans-Joachim Wittmann,et al.  Pharmacological Profile of Histaprodifens at Four Recombinant Histamine H1 Receptor Species Isoforms , 2008, Journal of Pharmacology and Experimental Therapeutics.

[83]  B. Damaj,et al.  Functional Expression of H4 Histamine Receptor in Human Natural Killer Cells, Monocytes, and Dendritic Cells , 2007, The Journal of Immunology.

[84]  R. Stevens,et al.  High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.

[85]  R. Seifert,et al.  Point mutations in the second extracellular loop of the histamine H2 receptor do not affect the species-selective activity of guanidine-type agonists , 2007, Naunyn-Schmiedeberg's Archives of Pharmacology.

[86]  H. de Haard,et al.  Properties, production, and applications of camelid single-domain antibody fragments , 2007, Applied Microbiology and Biotechnology.

[87]  M. Bouvier,et al.  The evasive nature of drug efficacy: implications for drug discovery. , 2007, Trends in pharmacological sciences.

[88]  Xavier Deupi,et al.  Conformational complexity of G-protein-coupled receptors. , 2007, Trends in pharmacological sciences.

[89]  R. Leurs,et al.  Histamine downregulates monocyte CCL2 production through the histamine H4 receptor. , 2007, The Journal of allergy and clinical immunology.

[90]  R. Leurs,et al.  In Vitro Pharmacology of Clinically Used Central Nervous System-Active Drugs as Inverse H1 Receptor Agonists , 2007, Journal of Pharmacology and Experimental Therapeutics.

[91]  R. Seifert,et al.  Mutations of Cys-17 and Ala-271 in the Human Histamine H2 Receptor Determine the Species Selectivity of Guanidine-Type Agonists and Increase Constitutive Activity , 2007, Journal of Pharmacology and Experimental Therapeutics.

[92]  M. Nishibori,et al.  Histamine H4 receptor agonists have more activities than H4 agonism in antigen‐specific human T‐cell responses , 2007, Immunology.

[93]  R. Seifert,et al.  Constitutive Activity and Ligand Selectivity of Human, Guinea Pig, Rat, and Canine Histamine H2 Receptors , 2007, Journal of Pharmacology and Experimental Therapeutics.

[94]  N. Takeda,et al.  Stimulation of histamine H1 receptor up-regulates histamine H1 receptor itself through activation of receptor gene transcription. , 2007, Journal of pharmacological sciences.

[95]  Arno Lukas,et al.  Identification of discontinuous antigenic determinants on proteins based on shape complementarities , 2007, Journal of molecular recognition : JMR.

[96]  Massimo Triggiani,et al.  Differentiation of monocytes into macrophages induces the upregulation of histamine H1 receptor. , 2007, The Journal of allergy and clinical immunology.

[97]  R. Seifert,et al.  Effects of Impromidine‐ and Arpromidine‐Derived Guanidines on Recombinant Human and Guinea Pig Histamine H1 and H2 Receptors , 2007, Archiv der Pharmazie.

[98]  R. Smits,et al.  Discovery of S-(2-guanidylethyl)-isothiourea (VUF 8430) as a potent nonimidazole histamine H4 receptor agonist. , 2006, Journal of medicinal chemistry.

[99]  Sun-Hee Kim,et al.  Isoliquiritigenin Selectively Inhibits H2 Histamine Receptor Signaling , 2006, Molecular Pharmacology.

[100]  T. Yoshino,et al.  Cimetidine Induces Interleukin-18 Production through H2-Agonist Activity in Monocytes , 2006, Molecular Pharmacology.

[101]  R. Smits,et al.  Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives. , 2006, Journal of medicinal chemistry.

[102]  R. Thurmond,et al.  The Histamine H4 Receptor Mediates Allergic Airway Inflammation by Regulating the Activation of CD4+ T Cells , 2006, The Journal of Immunology.

[103]  R. Seifert,et al.  N1-(3-Cyclohexylbutanoyl)-N2-[3-(1H-imidazol-4-yl)propyl]guanidine (UR-AK57), a Potent Partial Agonist for the Human Histamine H1- and H2-Receptors , 2006, Journal of Pharmacology and Experimental Therapeutics.

[104]  J. Arrang,et al.  Compared pharmacology of human histamine H3 and H4 receptors: structure–activity relationships of histamine derivatives , 2006, British journal of pharmacology.

[105]  R. Seifert,et al.  Probing Ligand-Specific Histamine H1- and H2-Receptor Conformations with NG-Acylated Imidazolylpropylguanidines , 2006, Journal of Pharmacology and Experimental Therapeutics.

[106]  C. Ganellin,et al.  Histamine and its receptors , 2006, British journal of pharmacology.

[107]  Rob Leurs,et al.  Evaluation of Histamine H1-, H2-, and H3-Receptor Ligands at the Human Histamine H4 Receptor: Identification of 4-Methylhistamine as the First Potent and Selective H4 Receptor Agonist , 2005, Journal of Pharmacology and Experimental Therapeutics.

[108]  M. Greaves Antihistamines in Dermatology , 2005, Skin Pharmacology and Physiology.

[109]  H. Stark,et al.  Histamine H4 Receptor Stimulation Suppresses IL-12p70 Production and Mediates Chemotaxis in Human Monocyte-Derived Dendritic Cells 1 , 2005, The Journal of Immunology.

[110]  R. Leurs,et al.  The histamine H3 receptor: from gene cloning to H3 receptor drugs , 2005, Nature Reviews Drug Discovery.

[111]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[112]  M. Babina,et al.  Human skin mast cells express H2 and H4, but not H3 receptors. , 2004, The Journal of investigative dermatology.

[113]  R. Thurmond,et al.  Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation , 2004, British journal of pharmacology.

[114]  Lars Karlsson,et al.  A Potent and Selective Histamine H4 Receptor Antagonist with Anti-Inflammatory Properties , 2004, Journal of Pharmacology and Experimental Therapeutics.

[115]  D. Richel,et al.  Activation of the Canonical β-Catenin Pathway by Histamine* , 2003, Journal of Biological Chemistry.

[116]  Arthur Christopoulos,et al.  International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology , 2003, Pharmacological Reviews.

[117]  T. Williams,et al.  Histamine induces cytoskeletal changes in human eosinophils via the H4 receptor , 2003, British journal of pharmacology.

[118]  J. Schwartz,et al.  Protean agonism at histamine H3 receptors in vitro and in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[119]  J. Williams,et al.  Partial agonist behaviour depends upon the level of nociceptin/orphanin FQ receptor expression: studies using the ecdysone‐inducible mammalian expression system , 2003, British journal of pharmacology.

[120]  C. Shayo,et al.  Tiotidine, a histamine H2 receptor inverse agonist that binds with high affinity to an inactive G-protein-coupled form of the receptor. Experimental support for the cubic ternary complex model. , 2003, Molecular pharmacology.

[121]  T. Bürckstümmer,et al.  Multiple Differences in Agonist and Antagonist Pharmacology between Human and Guinea Pig Histamine H1-Receptor , 2003, Journal of Pharmacology and Experimental Therapeutics.

[122]  F. Gantner,et al.  Histamine H4 and H2 Receptors Control Histamine-Induced Interleukin-16 Release from Human CD8+ T Cells , 2002, Journal of Pharmacology and Experimental Therapeutics.

[123]  R. Seifert,et al.  Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors , 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

[124]  F. Monsma,et al.  Molecular modeling and site-specific mutagenesis of the histamine-binding site of the histamine H4 receptor. , 2002, Molecular pharmacology.

[125]  John Dunlop,et al.  The role of transmembrane helix 5 in agonist binding to the human H3 receptor. , 2002, The Journal of pharmacology and experimental therapeutics.

[126]  F. Di Virgilio,et al.  Expression and function of histamine receptors in human monocyte-derived dendritic cells. , 2002, The Journal of allergy and clinical immunology.

[127]  T. Bürckstümmer,et al.  The human histamine H2‐receptor couples more efficiently to Sf9 insect cell Gs‐proteins than to insect cell Gq‐proteins: limitations of Sf9 cells for the analysis of receptor/Gq‐protein coupling , 2002, Journal of neurochemistry.

[128]  M. Trevethick,et al.  IDENTIFICATION OF A HISTAMINE H4 RECEPTOR ON HUMAN EOSINOPHILS—ROLE IN EOSINOPHIL CHEMOTAXIS , 2002, Journal of receptor and signal transduction research.

[129]  T. Bürckstümmer,et al.  Distinct interaction of human and guinea pig histamine H2-receptor with guanidine-type agonists. , 2001, Molecular pharmacology.

[130]  R. Seifert,et al.  Similar apparent constitutive activity of human histamine H(2)-receptor fused to long and short splice variants of G(salpha). , 2001, The Journal of pharmacology and experimental therapeutics.

[131]  A. Ortega,et al.  Histamine H1 Receptor Activation Stimulates Mitogenesis in Human Astrocytoma U373 MG Cells , 2001, Journal of Neuro-Oncology.

[132]  R. Leurs,et al.  Histamine H(1)-receptor activation of nuclear factor-kappa B: roles for G beta gamma- and G alpha(q/11)-subunits in constitutive and agonist-mediated signaling. , 2001, Molecular pharmacology.

[133]  L B Hough,et al.  Genomics meets histamine receptors: new subtypes, new receptors. , 2001, Molecular pharmacology.

[134]  F. Monsma,et al.  Cloning and characterization of a novel human histamine receptor. , 2001, The Journal of pharmacology and experimental therapeutics.

[135]  C R Ganellin,et al.  Distinct pharmacology of rat and human histamine H3 receptors: role of two amino acids in the third transmembrane domain , 2000, British journal of pharmacology.

[136]  Y. Masuho,et al.  Molecular Cloning and Characterization of a Novel Type of Histamine Receptor Preferentially Expressed in Leukocytes* , 2000, The Journal of Biological Chemistry.

[137]  C. Ezeamuzie,et al.  Histamine H2 receptors mediate the inhibitory effect of histamine on human eosinophil degranulation , 2000, British journal of pharmacology.

[138]  C. Shayo,et al.  Rapid desensitization and slow recovery of the cyclic AMP response mediated by histamine H(2) receptors in the U937 cell line. , 2000, Biochemical pharmacology.

[139]  D. Cooper,et al.  Characteristics of the Ca2+‐dependent inhibition of cyclic AMP accumulation by histamine and thapsigargin in human U373 MG astrocytoma cells , 2000, British journal of pharmacology.

[140]  T. Yoshino,et al.  Histamine Is a Potent Inducer of IL-18 and IFN-γ in Human Peripheral Blood Mononuclear Cells , 2000, The Journal of Immunology.

[141]  R. Kühne,et al.  Histaprodifens: synthesis, pharmacological in vitro evaluation, and molecular modeling of a new class of highly active and selective histamine H(1)-receptor agonists. , 2000, Journal of medicinal chemistry.

[142]  R. Leurs,et al.  Mutational Analysis of the Antagonist-binding Site of the Histamine H1 Receptor* , 1999, The Journal of Biological Chemistry.

[143]  A. Hancock,et al.  Analysis of Apparent Noncompetitive Responses to Competitive H1-Histamine Receptor Antagonists in Fluorescent Imaging Plate Reader-Based Calcium Assays , 1999, Journal of biomolecular screening.

[144]  M. Jackson,et al.  Cloning and functional expression of the human histamine H3 receptor. , 1999, Molecular pharmacology.

[145]  S. Hishinuma,et al.  Ca2+/Calmodulin‐Mediated Regulation of Agonist‐Induced Sequestration of Gq Protein‐Coupled Histamine H1 Receptors in Human U373 MG Astrocytoma Cells , 1998, Journal of neurochemistry.

[146]  B. Kobilka,et al.  Reconstitution of β2-adrenoceptor−GTP-binding-protein interaction in Sf9 cells , 1998 .

[147]  B. Kobilka,et al.  Different effects of Gsalpha splice variants on beta2-adrenoreceptor-mediated signaling. The Beta2-adrenoreceptor coupled to the long splice variant of Gsalpha has properties of a constitutively active receptor. , 1998, The Journal of biological chemistry.

[148]  B. Kobilka,et al.  Different Effects of Gsα Splice Variants on β2-Adrenoreceptor-mediated Signaling , 1998, The Journal of Biological Chemistry.

[149]  D. Leopoldt,et al.  G Proteins endogenously expressed in Sf 9 cells: interactions with mammalian histamine receptors , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

[150]  C. Shayo,et al.  Histamine modulates the expression of c-fos through cyclic AMP production via the H2 receptor in the human promonocytic cell line U937. , 1997, Molecular pharmacology.

[151]  T. Gudermann,et al.  G proteins of the Gq family couple the H2 histamine receptor to phospholipase C. , 1996, Molecular endocrinology.

[152]  Paul H. J. Nederkoorn,et al.  The agonistic binding site at the histamine H2 receptor. I. Theoretical investigations of histamine binding to an oligopeptide mimicking a part of the fifth transmembrane α-helix , 1996, J. Comput. Aided Mol. Des..

[153]  M. V. Regenmortel,et al.  Mapping Epitope Structure and Activity: From One-Dimensional Prediction to Four-Dimensional Description of Antigenic Specificity , 1996 .

[154]  R. Seifert,et al.  Receptor-independent G protein activation may account for the stimulatory effects of first-generation H1-receptor antagonists in HL-60 cells, basophils, and mast cells. , 1996, Biochemical pharmacology.

[155]  G. Cohen,et al.  Interactions of protein antigens with antibodies. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[156]  R. Leurs,et al.  Lysine200 located in the fifth transmembrane domain of the histamine H1 receptor interacts with histamine but not with all H1 agonists. , 1995, Biochemical and biophysical research communications.

[157]  M. Garbarg,et al.  Synthesis and histamine H1 receptor agonist activity of a series of 2-phenylhistamines, 2-heteroarylhistamines, and analogues. , 1995, Journal of medicinal chemistry.

[158]  G. Schultz,et al.  Histamine receptor-dependent and/or -independent activation of guanine nucleotide-binding proteins by histamine and 2-substituted histamine derivatives in human leukemia (HL-60) and human erythroleukemia (HEL) cells. , 1995, Biochemical pharmacology.

[159]  R. Seifert,et al.  Cationic-amphiphilic arpromidine-derived guanidines and a histamine trifluoromethyl-toluidide derivative may activate pertussis toxin-sensitive G-proteins by a receptor-independent mechanism , 1995, Naunyn-Schmiedeberg's Archives of Pharmacology.

[160]  G. Baumann,et al.  Haemodynamic profile of new H2-receptor agonists in congestive heart failure. , 1995, European journal of clinical investigation.

[161]  G. Schultz,et al.  The Drosophila cation channel trpl expressed in insect Sf9 cells is stimulated by agonists of G‐protein‐coupled receptors , 1995, FEBS letters.

[162]  H Hayashi,et al.  Site-directed mutagenesis of the histamine H1 receptor: roles of aspartic acid107, asparagine198 and threonine194. , 1994, Biochemical and biophysical research communications.

[163]  C. Szpirer,et al.  Stable expression of human H1-histamine-receptor cDNA in Chinese hamster ovary cells. Pharmacological characterisation of the protein, tissue distribution of messenger RNA and chromosomal localisation of the gene. , 1994, European journal of biochemistry.

[164]  R. Leurs,et al.  Pharmacological characterization of the human histamine H2 receptor stably expressed in Chinese hamster ovary cells , 1994, British journal of pharmacology.

[165]  E. Schulman,et al.  Pharmacologic characterization of a novel histamine receptor on human eosinophils. , 1994, American journal of respiratory and critical care medicine.

[166]  P. Vanhoutte,et al.  International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. , 1994, Pharmacological reviews.

[167]  R. Leurs,et al.  Site-directed mutagenesis of the histamine H1-receptor reveals a selective interaction of asparagine207 with subclasses of H1-receptor agonists. , 1994, Biochemical and biophysical research communications.

[168]  G. Schultz,et al.  Histamine H1-receptors in HL-60 monocytes are coupled to Gi-proteins and pertussis toxin-insensitive G-proteins and mediate activation of Ca2+ influx without concomitant Ca2+ mobilization from intracellular stores , 1994, Naunyn-Schmiedeberg’s Archives of Pharmacology.

[169]  C. Dinarello,et al.  Histamine enhances interleukin (IL)-1-induced IL-6 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells. , 1994, The Journal of biological chemistry.

[170]  G. Schultz,et al.  The H1 receptor agonist 2-(3-chlorophenyl)histamine activates Gi proteins in HL-60 cells through a mechanism that is independent of known histamine receptor subtypes. , 1994, Molecular pharmacology.

[171]  J. Young,et al.  Calcium‐dependence of histamine‐ and carbachol‐induced inositol phosphate formation in human U373 MG astrocytoma cells: comparison with HeLa cells and brain slices , 1994, British journal of pharmacology.

[172]  J. Leysen,et al.  Genomic cloning, heterologous expression and pharmacological characterization of a human histamine H1 receptor. , 1993, Biochemical and biophysical research communications.

[173]  C. Dinarello,et al.  Histamine enhances interleukin (IL)-1-induced IL-1 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells. Comparison with IL-1 receptor antagonist. , 1993, The Journal of clinical investigation.

[174]  J. Williams,et al.  Protein kinase C inhibits cyclic adenosine monophosphate generation by histamine and truncated glucagon like peptide 1 in the human gastric cancer cell line HGT-1. , 1993, Gut.

[175]  Yi-Jun Guo,et al.  Molecular basis for the interaction of histamine with the histamine H2 receptor. , 1992, The Journal of biological chemistry.

[176]  R. Leurs,et al.  Short‐term desensitization of the histamine H1 receptor in human HeLa cells: involvement of protein kinase C dependent and independent pathways , 1992, British journal of pharmacology.

[177]  H. Timmerman,et al.  Histamine H2-receptor agonists. Synthesis, in vitro pharmacology, and qualitative structure-activity relationships of substituted 4- and 5-(2-aminoethyl)thiazoles. , 1992, Journal of medicinal chemistry.

[178]  R. Seifert,et al.  Histamine increases cytosolic Ca2+ in HL-60 promyelocytes predominantly via H2 receptors with an unique agonist/antagonist profile and induces functional differentiation. , 1992, Molecular pharmacology.

[179]  R. Seifert,et al.  Histamine increases cytosolic Ca2+ in dibutyryl-cAMP-differentiated HL-60 cells via H1 receptors and is an incomplete secretagogue. , 1992, Molecular pharmacology.

[180]  E. Schulman,et al.  Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils. , 1992, Journal of immunology.

[181]  J. Ballesteros,et al.  Analysis and refinement of criteria for predicting the structure and relative orientations of transmembranal helical domains. , 1992, Biophysical journal.

[182]  T. Yamada,et al.  Molecular cloning of the human histamine H2 receptor. , 1991, Biochemical and biophysical research communications.

[183]  Y. Hattori,et al.  Identification and characterization of histamine H1‐ and H2‐receptors in guinea‐pig left atrial membranes by [3H]‐mepyramine and [3H]‐tiotidine binding , 1991, British journal of pharmacology.

[184]  T. Chiba,et al.  Presence of histamine H2-receptors on human gastric carcinoma cell line MKN-45 and their increase by retinoic acid treatment. , 1991, Biochemical and biophysical research communications.

[185]  R. Seifert,et al.  Characterization of histamine H2-receptors in human neutrophils with a series of guanidine analogues of impromidine , 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

[186]  I. Verlaan,et al.  Histamine as a growth factor and chemoattractant for human carcinoma and melanoma cells: action through Ca2(+)-mobilizing H1 receptors , 1990, The Journal of cell biology.

[187]  G. Schultz,et al.  Histamine inhibits activation of human neutrophils and HL-60 leukemic cells via H2-receptors , 1989, Naunyn-Schmiedeberg's Archives of Pharmacology.

[188]  M. Mitsuhashi,et al.  Multiple signaling pathways of histamine H2 receptors. Identification of an H2 receptor-dependent Ca2+ mobilization pathway in human HL-60 promyelocytic leukemia cells. , 1989, The Journal of biological chemistry.

[189]  R. Cramer,et al.  Validation of the general purpose tripos 5.2 force field , 1989 .

[190]  A. Buschauer Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs. , 1989, Journal of medicinal chemistry.

[191]  C. Gespach,et al.  Pharmacology of histamine H2 receptor antagonists in the human gastric cancer cell line HGT-1. Structure-activity relationship of isocytosine-furan and imidazole derivatives related to cimetidine. , 1986, Biochemical pharmacology.

[192]  J. Abita,et al.  Histamine H2 receptor activity during the differentiation of the human monocytic‐like cell line U‐937 , 1985, FEBS letters.

[193]  C. Gespach,et al.  Desensitization by histamine of H2 receptor‐mediated adenylate cyclase activation in the human gastric cancer cell line HGT‐1 , 1984, FEBS letters.

[194]  C. L. Johnson,et al.  Histamine H2 receptor desensitization in HL-60 human promyelocytic leukemia cells. , 1984, The Journal of pharmacology and experimental therapeutics.

[195]  C. Gespach,et al.  Irreversible and specific inactivation by AH 22216 of histamine H2 receptors in the human gastric cancer cell line HGT-1. , 1983, Biochemical and biophysical research communications.

[196]  B. Seligmann,et al.  Histamine modulation of human neutrophil oxidative metabolism, locomotion, degranulation, and membrane potential changes. , 1983, Journal of immunology.

[197]  J. Abita,et al.  Identification and characterization of surface receptors for histamine in the human promyelocytic leukemia cell line HL-60. Comparison with human peripheral neutrophils. , 1982, Molecular pharmacology.

[198]  C. Laboisse,et al.  Characterization of a newly established human gastric cancer cell line HGT-1 bearing histamine H2-receptors. , 1982, Cancer research.

[199]  W. Duncan,et al.  Impromidine (SK&F 92676) is a very potent and specific agonist for histamine H2 receptors , 1978, Nature.

[200]  W. Busse,et al.  Decreased H2 histamine response of granulocytes of asthmatic patients. , 1977, The Journal of clinical investigation.

[201]  W. Busse,et al.  Histamine inhibition of neutrophil lysosomal enzyme release: an H2 histamine receptor response. , 1976, Science.

[202]  J. Black,et al.  Definition and Antagonism of Histamine H2-receptors , 1972, Nature.

[203]  Hans-Joachim Wittmann,et al.  Species-dependent activities of G-protein-coupled receptor ligands: lessons from histamine receptor orthologs. , 2013, Trends in pharmacological sciences.

[204]  S. Hishinuma,et al.  The affinity of histamine for Gq protein-coupled histamine H(1)-receptors is predominantly regulated by their internalization in human astrocytoma cells. , 2012, Journal of pharmacological sciences.

[205]  J. Ortonne Urticaria and its subtypes: the role of second-generation antihistamines. , 2012, European journal of internal medicine.

[206]  C. Perry,et al.  Histamine Dihydrochloride , 2012, Drugs.

[207]  R. Gutzmer,et al.  Human memory Th17 cells express a functional histamine H4 receptor. , 2012, The American journal of pathology.

[208]  G. Reynolds,et al.  Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms. , 2010, Pharmacology and Therapeutics.

[209]  R. Seifert,et al.  Coexpression systems as models for the analysis of constitutive GPCR activity. , 2010, Methods in enzymology.

[210]  R. Seifert,et al.  Fusion proteins as model systems for the analysis of constitutive GPCR activity. , 2010, Methods in enzymology.

[211]  J. Mullol,et al.  Allergic conjunctivitis and H1 antihistamines. , 2009, Journal of investigational allergology & clinical immunology.

[212]  S. Hishinuma,et al.  Intact cell binding for in vitro prediction of sedative and non-sedative histamine H1-receptor antagonists based on receptor internalization. , 2008, Journal of pharmacological sciences.

[213]  Erwin W. Gelfand,et al.  The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines , 2008, Nature Reviews Drug Discovery.

[214]  T. Kuroki,et al.  Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis. , 2008, Progress in brain research.

[215]  P. Desai,et al.  Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. , 2007, The Journal of allergy and clinical immunology.

[216]  R. Seifert,et al.  Stimulation of histamine H2- (and H1)-receptors activates Ca2+ influx in all-atrans-retinoic acid-differentiated HL-60 cells independently of phospholipase C or adenylyl cyclase , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[217]  J. Massagué TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[218]  J. Schwartz,et al.  Novel Histamine H3‐Receptor Antagonists with Benzyl Ether Structure or Related Moieties: Synthesis and Structure‐Activity Relationships , 1996, Archiv der Pharmazie.

[219]  J. Abita,et al.  Human polymorphonuclear neutrophils. Pharmacological characterization of histamine receptors mediating the elevation of cyclic AMP. , 1982, Molecular pharmacology.

[220]  R. Thurmond,et al.  Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Pharmacological Characterization of Oxime Agonists of the Histamine H 4 Receptor , 2022 .